Company intelligence / Profile preview

Toray Medical Co., Ltd.

Tokyo, Japan

Ownership: Private
Employees: ~463
Development stage: Other

Overview

Toray Medical develops and markets dialysis devices, critical care products like hemoperfusion cartridges and hemofilters, and pharmaceuticals including natural interferon-β (Feron®) for viral hepatitis and cancers, and nalfurafine hydrochloride (NOPICOR®/Remitch®) for pruritus in hemodialysis patients.

Therapeutic areas: NephrologyCardiovascularDermatologyInfectious DiseasesOncology
Modalities: DeviceProteinSmall molecule
Industry: Biotech

Partnerships

MSD K.K. (for Rebetol® combination)

Beyond the preview

Go deeper on Toray Medical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toray Medical Co., Ltd..

Explore the full profile